Patent ID: 7112322

Claim:
A method for prevention of atopic diseases selected from the group consisting of atopic eczema, allergic rhinitis and asthma in an infant at high risk of said atopic diseases, comprising administering to a pregnant woman a daily dose of live probiotic bacteria in an amount of about 1×10 8 to about 1×10 10 colony forming units of the probiotic bacteria for at least two weeks before infant delivery, and after infant delivery, administering directly to the newborn infant of said pregnant woman a daily dose of live probiotic bacteria in an amount of about 1×10 8 to about 1×10 10 colony forming units of the probiotic bacteria for at least 2 months; wherein said probiotic bacteria are selected from the group consisting of Lactobacillus casei spp. rhamnosus ATCC 53103 and Bifidobacterium lactis Bb-12.